IMPORTANT: PLEASE READ CAREFULLY BEFORE SIGNING. SIGNIFICANT REPRESENTATIONS ARE CALLED FOR HEREIN. SUBSCRIPTION AGREEMENT and LETTER OF INVESTMENT INTENTSubscription Agreement • August 14th, 2013 • Omni Bio Pharmaceutical, Inc. • Biological products, (no disgnostic substances) • Colorado
Contract Type FiledAugust 14th, 2013 Company Industry Jurisdiction
AMENDMENT TWO TO SPONSORED RESEARCH AGREEMENTSponsored Research Agreement • August 14th, 2013 • Omni Bio Pharmaceutical, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledAugust 14th, 2013 Company IndustryThis Amendment made this 1st day of July, 2013 by and between the THE REGENTS OF THE UNIVERSITY OF COLORADO, a body corporate, contracting for and on behalf of the University of Colorado Denver, a public institution of higher education created under the Constitution and the Law of the State of Colorado (hereinafter referred to as “UNIVERSITY”) and Omni Bio Pharmaceutical, Inc. hereinafter referred to as “Sponsor”.